Joanna Jacobus1,2, Lindsay M Squeglia3, Silvia Escobar4, Benjamin M McKenna5,4, Margie Mejia Hernandez4, Kara S Bagot4, Charles T Taylor4, Marilyn A Huestis6. 1. Veterans Affairs San Diego Healthcare System, San Diego, CA, USA. jjacobus@ucsd.edu. 2. Department of Psychiatry, University of California San Diego, La Jolla, CA, USA. jjacobus@ucsd.edu. 3. Department of Psychiatry and Behavioral Sciences, Addiction Sciences Division, Medical University of South Carolina, Charleston, SC, USA. 4. Department of Psychiatry, University of California San Diego, La Jolla, CA, USA. 5. Veterans Affairs San Diego Healthcare System, San Diego, CA, USA. 6. School of Medicine, University of Maryland, Baltimore, MD, USA.
Abstract
RATIONALE: Advancing marijuana prevention and intervention efforts are important given the decreasing perception of harm among adolescents and increasing marijuana legalization. OBJECTIVES: This study evaluates how a monitored abstinence protocol may contribute to emotional functioning and changes in marijuana problems that can enhance successful outcomes for non-treatment-seeking adolescent marijuana users. METHODS: Adolescent marijuana users (n = 26) and demographically matched controls (n = 30) completed 28 days of monitored abstinence confirmed by biweekly urine toxicology. Participants were given measures of emotional functioning, marijuana use symptoms, and reward sensitivity during monitored abstinence. RESULTS: All participants (n = 56) completed the protocol, and 69% of marijuana users (n = 18 of 26) were confirmed abstinent for 28 days, with all users showing decreasing marijuana use. Reductions in subsyndromal depression, positive marijuana use expectancies, and poor sleep quality were observed by the end of the monitored abstinence period (n = 26, p values < .05). Marijuana users also reported more attentional impulsivity and less responsiveness to reward stimuli during the second week of abstinence compared to controls. Later age of onset of regular marijuana use and more cumulative lifetime use were associated with a greater degree of emotional change and increased recognition of the negative effects of marijuana use. CONCLUSIONS: Monitored abstinence programs may be beneficial in reducing marijuana use, subsyndromal emotional distress symptoms, and changing beliefs about marijuana use. Future prevention and intervention efforts may consider targeting reward sensitivity and impulsivity, in addition to marijuana use, expectancies, and emotional functioning.
RATIONALE: Advancing marijuana prevention and intervention efforts are important given the decreasing perception of harm among adolescents and increasing marijuana legalization. OBJECTIVES: This study evaluates how a monitored abstinence protocol may contribute to emotional functioning and changes in marijuana problems that can enhance successful outcomes for non-treatment-seeking adolescent marijuana users. METHODS: Adolescent marijuana users (n = 26) and demographically matched controls (n = 30) completed 28 days of monitored abstinence confirmed by biweekly urine toxicology. Participants were given measures of emotional functioning, marijuana use symptoms, and reward sensitivity during monitored abstinence. RESULTS: All participants (n = 56) completed the protocol, and 69% of marijuana users (n = 18 of 26) were confirmed abstinent for 28 days, with all users showing decreasing marijuana use. Reductions in subsyndromal depression, positive marijuana use expectancies, and poor sleep quality were observed by the end of the monitored abstinence period (n = 26, p values < .05). Marijuana users also reported more attentional impulsivity and less responsiveness to reward stimuli during the second week of abstinence compared to controls. Later age of onset of regular marijuana use and more cumulative lifetime use were associated with a greater degree of emotional change and increased recognition of the negative effects of marijuana use. CONCLUSIONS: Monitored abstinence programs may be beneficial in reducing marijuana use, subsyndromal emotional distress symptoms, and changing beliefs about marijuana use. Future prevention and intervention efforts may consider targeting reward sensitivity and impulsivity, in addition to marijuana use, expectancies, and emotional functioning.
Authors: Andrea Prince van Leeuwen; Hanneke E Creemers; Frank C Verhulst; Johan Ormel; Anja C Huizink Journal: J Stud Alcohol Drugs Date: 2011-01 Impact factor: 2.582
Authors: Donald M Dougherty; Charles W Mathias; Michael A Dawes; R Michael Furr; Nora E Charles; Anthony Liguori; Erin E Shannon; Ashley Acheson Journal: Psychopharmacology (Berl) Date: 2012-11-09 Impact factor: 4.530
Authors: Jillian E Halladay; Michael H Boyle; Catharine Munn; Susan M Jack; Katholiki Georgiades Journal: Can J Psychiatry Date: 2018-09-27 Impact factor: 4.356
Authors: Alexandra M Zuckermann; Mahmood R Gohari; Margaret de Groh; Ying Jiang; Scott T Leatherdale Journal: Health Promot Chronic Dis Prev Can Date: 2020-04 Impact factor: 3.240
Authors: Rachel L Tomko; Nathaniel L Baker; Caitlyn O Hood; Amanda K Gilmore; Erin A McClure; Lindsay M Squeglia; Aimee L McRae-Clark; Susan C Sonne; Kevin M Gray Journal: Psychopharmacology (Berl) Date: 2019-11-11 Impact factor: 4.530
Authors: Laika D Aguinaldo; Lindsay M Squeglia; Kevin M Gray; Clarisa Coronado; Briana Lees; Rachel L Tomko; Joanna Jacobus Journal: Curr Addict Rep Date: 2019-11-15
Authors: Megan E Cooke; Jodi M Gilman; Erin Lamberth; Natali Rychik; Brenden Tervo-Clemmens; A Eden Evins; Randi M Schuster Journal: Front Psychiatry Date: 2021-07-01 Impact factor: 4.157